Staff Reports
The American Medical Association and the Vaccine Integrity Project have just published an independent evidence review and a set of vaccine recommendations for the upcoming respiratory virus season. They also teamed with JAMA to publish companion scientific reviews and launched a public resource hub to explain the findings. It is important — both for public health and for how we decide who gets to make the rules.
Independent review fills the gap
The Vaccine Integrity Project and the AMA reviewed hundreds of studies on influenza, COVID‑19 and RSV to produce guidance for clinicians and families. JAMA ran three companion evidence‑review papers and a perspective piece that summarize the science behind the recommendations. In plain English: an independent team looked at the evidence and said vaccines still cut hospitalizations and deaths, and they found no new safety red flags in the studies they examined.
What the AMA and partners are actually recommending
The consolidated guidance is straight forward. The AMA recommends annual flu shots for nearly everyone 6 months and older. It advises COVID‑19 shots for the youngest children (6–23 months) and for older children in certain risk groups, with stronger booster recommendations for older and immunocompromised adults. For RSV, the advice leans on maternal vaccination and targeted infant protection when maternal coverage is missing, and age‑based RSV shots for older adults at higher risk. Specialty societies helped shape the guidance so clinicians have clear, usable advice.
Why this matters — trust, transparency and who sets policy
Here’s the political bit: this independent effort didn’t happen in a vacuum. It followed disruptions in the usual federal advisory process, so medical societies and independent researchers stepped in to provide clear guidance. That’s both good and worth watching. Good because it pushes transparency and gives doctors tools to counsel patients. Worth watching because recommendations can easily drift into pressure or mandates if policymakers treat them as commandments instead of guidance. As Michael T. Osterholm, Executive Director of the Vaccine Integrity Project, put it, immunization remains one of our best tools — and Sandra Adamson Fryhofer of the AMA stressed the need for clear, evidence‑based information. Fair enough — but “clear” should not mean “coercive.”
Bottom line for families and clinicians
The new independent review and the AMA’s consolidated recommendations provide useful, science‑based direction for the season ahead. If you’re a parent or patient, talk to your doctor about your family’s risks and choices. If you’re a policymaker, don’t confuse guidance with a mandate. Protecting public health and protecting individual choice are not contradictory — they’re both required if trust in medicine is going to hold. The AMA and the Vaccine Integrity Project did the heavy lifting on the evidence. Now it’s up to clinicians and families to use that information wisely, not blindly.
